Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
A novel α4/7-conotoxin LvIA from Conus lividus that selectively blocks α3β2 vs. α6/α3β2β3 nicotinic acetylcholine receptors.
Luo S, Zhangsun D, Schroeder CI, Zhu X, Hu Y, Wu Y, Weltzin MM, Eberhard S, Kaas Q, Craik DJ, McIntosh JM, Whiteaker P.
???displayArticle.abstract???
This study was performed to discover and characterize the first potent α3β2-subtype-selective nicotinic acetylcholine receptor (nAChR) ligand. A novel α4/7-conotoxin, α-CTxLvIA, was cloned from Conus lividus. Its pharmacological profile at Xenopus laevis oocyte-expressed rat nAChR subtypes was determined by 2-electrode voltage-clamp electrophysiology, and its 3-dimensional (3D) structure was determined by NMR spectroscopy. α-CTx LvIA is a 16-aa C-terminally-amidated peptide with 2-disulfide bridges. Using rat subunits expressed in Xenopus oocytes, we found the highest affinity of α-CTxLvIA was for α3β2 nAChRs (IC50 8.7 nM), where blockade was reversible within 2 min. IC50 values were >100 nM at α6/α3β2β3, α6/α3β4, and α3β4 nAChRs, and ≥3 μM at all other subtypes tested. α3β2 vs. α6β2 subtype selectivity was confirmed for human-subunit nAChRs with much greater preference (300-fold) for α3β2 over α6β2 nAChRs. This is the first α-CTx reported to show high selectivity for human α3β2 vs. α6β2 nAChRs. α-CTxLvIA adopts two similarly populated conformations water: one (assumed to be bioactive) is highly structured, whereas the other is mostly random coil in nature. Selectivity differences with the similarly potent, but less selective, α3β2 nAChR antagonist α-CTx PeIA probably reside within the three residues, which differ in loop 2, given their otherwise similar 3D structures. α4/7-CTx LvIA is a new, potent, selective α3β2 nAChR antagonist, which will enable detailed studies of α3β2 nAChR structure, function, and physiological roles.
Armishaw,
Establishing regiocontrol of disulfide bond isomers of alpha-conotoxin ImI via the synthesis of N-to-C cyclic analogs.
2010, Pubmed
Armishaw,
Establishing regiocontrol of disulfide bond isomers of alpha-conotoxin ImI via the synthesis of N-to-C cyclic analogs.
2010,
Pubmed Bartels,
The program XEASY for computer-supported NMR spectral analysis of biological macromolecules.
1995,
Pubmed Brünger,
Crystallography & NMR system: A new software suite for macromolecular structure determination.
1998,
Pubmed Cartier,
A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors.
1996,
Pubmed
,
Xenbase Celie,
Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an alpha-conotoxin PnIA variant.
2005,
Pubmed
,
Xenbase Champtiaux,
Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice.
2003,
Pubmed Chen,
MolProbity: all-atom structure validation for macromolecular crystallography.
2010,
Pubmed Cierpicki,
Amide proton temperature coefficients as hydrogen bond indicators in proteins.
2001,
Pubmed Clark,
The synthesis, structural characterization, and receptor specificity of the alpha-conotoxin Vc1.1.
2006,
Pubmed
,
Xenbase Clark,
The engineering of an orally active conotoxin for the treatment of neuropathic pain.
2010,
Pubmed Clarke,
Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin.
1985,
Pubmed Corpuz,
Definition of the M-conotoxin superfamily: characterization of novel peptides from molluscivorous Conus venoms.
2005,
Pubmed Daly,
Structure and activity of alpha-conotoxin PeIA at nicotinic acetylcholine receptor subtypes and GABA(B) receptor-coupled N-type calcium channels.
2011,
Pubmed
,
Xenbase Dominguez,
HADDOCK: a protein-protein docking approach based on biochemical or biophysical information.
2003,
Pubmed Dowell,
Alpha-conotoxin PIA is selective for alpha6 subunit-containing nicotinic acetylcholine receptors.
2003,
Pubmed
,
Xenbase Duckert,
Prediction of proprotein convertase cleavage sites.
2004,
Pubmed Dutton,
alpha-Conotoxins: nicotinic acetylcholine receptor antagonists as pharmacological tools and potential drug leads.
2001,
Pubmed Franco,
RegIIA: an α4/7-conotoxin from the venom of Conus regius that potently blocks α3β4 nAChRs.
2012,
Pubmed
,
Xenbase Gehrmann,
Structure determination of the three disulfide bond isomers of alpha-conotoxin GI: a model for the role of disulfide bonds in structural stability.
1998,
Pubmed Gotti,
Structural and functional diversity of native brain neuronal nicotinic receptors.
2009,
Pubmed Gotti,
Neuronal nicotinic receptors: from structure to pathology.
2004,
Pubmed Gotti,
Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation.
2006,
Pubmed Güntert,
Torsion angle dynamics for NMR structure calculation with the new program DYANA.
1997,
Pubmed Halai,
Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.
2009,
Pubmed
,
Xenbase Hogg,
Alpha-conotoxins PnIA and [A10L]PnIA stabilize different states of the alpha7-L247T nicotinic acetylcholine receptor.
2003,
Pubmed
,
Xenbase Hogg,
Single amino acid substitutions in alpha-conotoxin PnIA shift selectivity for subtypes of the mammalian neuronal nicotinic acetylcholine receptor.
1999,
Pubmed Hone,
α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.
2012,
Pubmed
,
Xenbase Jacobsen,
Critical residues influence the affinity and selectivity of alpha-conotoxin MI for nicotinic acetylcholine receptors.
1999,
Pubmed
,
Xenbase Jin,
Structure of alpha-conotoxin BuIA: influences of disulfide connectivity on structural dynamics.
2007,
Pubmed
,
Xenbase Kaas,
ConoServer, a database for conopeptide sequences and structures.
2008,
Pubmed Kaas,
ConoServer: updated content, knowledge, and discovery tools in the conopeptide database.
2012,
Pubmed Kasheverov,
Naturally occurring and synthetic peptides acting on nicotinic acetylcholine receptors.
2009,
Pubmed Koradi,
MOLMOL: a program for display and analysis of macromolecular structures.
1996,
Pubmed Kuryatov,
Human alpha6 AChR subtypes: subunit composition, assembly, and pharmacological responses.
2000,
Pubmed
,
Xenbase Letchworth,
Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors.
2011,
Pubmed Linge,
Influence of non-bonded parameters on the quality of NMR structures: a new force field for NMR structure calculation.
1999,
Pubmed Lukas,
International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits.
1999,
Pubmed Luo,
Characterization of a novel α-conotoxin from conus textile that selectively targets α6/α3β2β3 nicotinic acetylcholine receptors.
2013,
Pubmed
,
Xenbase Marion,
Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins.
1983,
Pubmed McClure-Begley,
A novel α-conotoxin MII-sensitive nicotinic acetylcholine receptor modulates [(3) H]-GABA release in the superficial layers of the mouse superior colliculus.
2012,
Pubmed McIntosh,
Alpha-conotoxin GIC from Conus geographus, a novel peptide antagonist of nicotinic acetylcholine receptors.
2002,
Pubmed
,
Xenbase McIntosh,
A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
2005,
Pubmed
,
Xenbase McIntosh,
Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes.
1999,
Pubmed McIntosh,
Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors.
2004,
Pubmed
,
Xenbase Muttenthaler,
Structure-activity studies on alpha-conotoxins.
2011,
Pubmed Nederveen,
RECOORD: a recalculated coordinate database of 500+ proteins from the PDB using restraints from the BioMagResBank.
2005,
Pubmed Nevin,
Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins?
2007,
Pubmed
,
Xenbase Nicke,
Alpha-conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypes.
2004,
Pubmed Nielsen,
Solution structure of mu-conotoxin PIIIA, a preferential inhibitor of persistent tetrodotoxin-sensitive sodium channels.
2002,
Pubmed Norton,
Conotoxins down under.
2006,
Pubmed Olsson,
PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions.
2011,
Pubmed Peng,
Characterization of a novel alpha4/4-conotoxin, Qc1.2, from vermivorous Conus quercinus.
2009,
Pubmed
,
Xenbase Quik,
Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders.
2011,
Pubmed Rance,
Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering.
1983,
Pubmed Sali,
Comparative protein modelling by satisfaction of spatial restraints.
1993,
Pubmed Santos,
The A-superfamily of conotoxins: structural and functional divergence.
2004,
Pubmed Shen,
Statistical potential for assessment and prediction of protein structures.
2006,
Pubmed Shen,
TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts.
2009,
Pubmed Shiraki,
Trifluoroethanol-induced stabilization of the alpha-helical structure of beta-lactoglobulin: implication for non-hierarchical protein folding.
1995,
Pubmed Søndergaard,
Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values.
2011,
Pubmed Talley,
Alpha-conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as alpha3beta2 and alpha7 nicotinic acetylcholine receptors.
2006,
Pubmed
,
Xenbase Teichert,
Definition and characterization of the short alphaA-conotoxins: a single residue determines dissociation kinetics from the fetal muscle nicotinic acetylcholine receptor.
2006,
Pubmed
,
Xenbase Terlau,
Conus venoms: a rich source of novel ion channel-targeted peptides.
2004,
Pubmed Vincler,
Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors.
2006,
Pubmed Whiteaker,
125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain.
2000,
Pubmed Whiteaker,
Involvement of the alpha3 subunit in central nicotinic binding populations.
2002,
Pubmed Young,
Spinal alpha3beta2* nicotinic acetylcholine receptors tonically inhibit the transmission of nociceptive mechanical stimuli.
2008,
Pubmed Yu,
Blockade of neuronal α7-nAChR by α-conotoxin ImI explained by computational scanning and energy calculations.
2011,
Pubmed Yu,
Determination of the α-conotoxin Vc1.1 binding site on the α9α10 nicotinic acetylcholine receptor.
2013,
Pubmed
